Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CALIPER LIFE SCIENCES INC | 108,101 | reported | 03 Jun 2008 | tx 109+127,141−153,000 |
| LPATH INC | 25,000 | reported | 16 Feb 2016 | tx 5+141,602 |
| SEQUENOM INC | 15,000 | reported | 14 May 2004 | tx 1+15,000 |
| Conatus Pharmaceuticals Inc | 6,835 | reported | 20 Jun 2023 | tx 14+185,435 |
| GTX INC /DE/ | 2,200 | reported | 20 Jun 2024 | tx 10+137,200−45,000 |
| Zynerba Pharmaceuticals, Inc. | 0 | reported | 10 Oct 2023 | tx 18+299,832−182,332 |
| DYNAVAX TECHNOLOGIES CORP | 0 | reported | 10 Feb 2026 | tx 34+361,029−189,329 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2026 | TENDER | DYNAVAX TECHNOLOGIES CORP | 1,500 | — | |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 21,829 | — | |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 22,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 25,000 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 22,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 22,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 28,500 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 25,000 | — | deriv |
| 10 Feb 2026 | OTHER | DYNAVAX TECHNOLOGIES CORP | 15,000 | — | deriv |
| 11 Jun 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 5,758 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 28,500 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | GTX INC /DE/ | 2,200 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 5,357 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 22,500 | 0.00 USD | deriv |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 27,954 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 47,824 | — | |
| 10 Oct 2023 | OTHER | Zynerba Pharmaceuticals, Inc. | 71,736 | — | deriv |
| 10 Oct 2023 | OTHER | Zynerba Pharmaceuticals, Inc. | 34,663 | — | deriv |
| 28 Jun 2023 | GRANT_AWARD | GTX INC /DE/ | 25,000 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | Conatus Pharmaceuticals Inc | 6,835 | 0.00 USD | deriv |
| 14 Jun 2023 | SALE | Zynerba Pharmaceuticals, Inc. | 115 | 0.35 USD | |
| 13 Jun 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 47,824 | 0.00 USD | |
| 13 Jun 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 71,736 | 0.00 USD | deriv |
| 26 May 2023 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 5,357 | 0.00 USD | |
| 26 May 2023 | GRANT_AWARD | DYNAVAX TECHNOLOGIES CORP | 22,500 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 21 Jul 2020.